Loading…
Immunohistochemical Detection of WT1 Protein in Endometrial Cancer
Background: The Wilms' tumor gene WT1 is overexpressed in various kinds of solid tumors. However, it remains unclear whether WT1 plays a pathophysiological role in endometrial cancer. Patients and Methods: A series of 70 endometrial cancer patients who had undergone a curative resection was stu...
Saved in:
Published in: | Anticancer research 2009-05, Vol.29 (5), p.1691-1695 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: The Wilms' tumor gene WT1 is overexpressed in various kinds of solid tumors. However, it remains unclear whether
WT1 plays a pathophysiological role in endometrial cancer. Patients and Methods: A series of 70 endometrial cancer patients
who had undergone a curative resection was studied to determine the correlation between WT1 expression, clinicopathological
characteristics and prognosis. Tissue specimens were evaluated for WT1 expression by immunohistochemistry. Results: The expression
of WT1 was strong in 31 patients (44%) and weak in 39 patients (56%). WT1 overexpression was associated with advanced FIGO
stage (p=0.0266), myometrial invasion (p=0.0477) and high-grade histological differentiation (p=0.0049). The expression level
of WT1 was found to be a significant predictor of disease relapse in univariate analysis (p=0.0233), but not in multivariate
analysis (p=0.4757). Conclusion: These results suggested that tumor-produced WT1 provided additional prognostic information
in endometrial cancer patients. |
---|---|
ISSN: | 0250-7005 1791-7530 |